Gilead Sciences
GILD
#127
Rank
โ‚น13.976 T
Marketcap
โ‚น11,264
Share price
0.38%
Change (1 day)
42.74%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): โ‚น858.50 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are โ‚น29.08 Billion. In 2024 the company made an earning of โ‚น61.84 Billion a decrease over its 2023 earnings that were of โ‚น614.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น858.50 B1288.15%
2024 โ‚น61.84 B-89.94%
2023 โ‚น614.77 B17.97%
2022 โ‚น521.11 B-29.77%
2021 โ‚น741.96 B395.99%
2020 โ‚น149.59 B-67.66%
2019 โ‚น462.49 B-33.84%
2018 โ‚น699.03 B-42.35%
2017 โ‚น1.212 T-20.87%
2016 โ‚น1.532 T-21.06%
2015 โ‚น1.941 T45.8%
2014 โ‚น1.331 T253.01%
2013 โ‚น377.18 B16.51%
2012 โ‚น323.74 B-1.07%
2011 โ‚น327.24 B-6.71%
2010 โ‚น350.77 B11.75%
2009 โ‚น313.88 B29.5%
2008 โ‚น242.38 B19.11%
2007 โ‚น203.49 B-455.74%
2006 -โ‚น57.21 Billion-154.93%
2005 โ‚น104.13 B76.99%
2004 โ‚น58.83 B-266.16%
2003 -โ‚น35.41 Billion-638.24%
2002 โ‚น6.57 B31.5%
2001 โ‚น5.00 B-242.15%
2000 -โ‚น3.52 Billion-40.2%
1999 -โ‚น5.89 Billion31.85%
1998 -โ‚น4.47 Billion8.73%
1997 -โ‚น4.11 Billion27.22%
1996 -โ‚น3.23 Billion
1994 -โ‚น3.08 Billion26.57%
1993 -โ‚น2.43 Billion46.49%
1992 -โ‚น1.66 Billion362.5%
1991 -โ‚น0.36 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น738.91 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น399.88 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น148.78 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น89.18 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น170.65 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.062 T 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.903 T 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.017 T 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.069 T 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA